Cardiovascular Systems (NASDAQ:CSII) and Amedica (NASDAQ:AMDA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Analyst Recommendations

This is a summary of current recommendations and price targets for Cardiovascular Systems and Amedica, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardiovascular Systems 0 3 4 0 2.57
Amedica 0 2 0 0 2.00

Cardiovascular Systems presently has a consensus price target of $37.00, suggesting a potential downside of 5.73%. Given Cardiovascular Systems’ stronger consensus rating and higher possible upside, research analysts plainly believe Cardiovascular Systems is more favorable than Amedica.

Earnings & Valuation

This table compares Cardiovascular Systems and Amedica’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cardiovascular Systems $217.04 million 6.06 $1.71 million $0.05 785.00
Amedica $11.22 million 0.28 -$9.32 million N/A N/A

Cardiovascular Systems has higher revenue and earnings than Amedica.

Profitability

This table compares Cardiovascular Systems and Amedica’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cardiovascular Systems 0.79% 1.36% 0.88%
Amedica -139.44% -148.66% -67.85%

Volatility and Risk

Cardiovascular Systems has a beta of 2.45, suggesting that its share price is 145% more volatile than the S&P 500. Comparatively, Amedica has a beta of -1.31, suggesting that its share price is 231% less volatile than the S&P 500.

Institutional and Insider Ownership

84.6% of Cardiovascular Systems shares are held by institutional investors. Comparatively, 3.7% of Amedica shares are held by institutional investors. 3.3% of Cardiovascular Systems shares are held by company insiders. Comparatively, 0.9% of Amedica shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Cardiovascular Systems beats Amedica on 12 of the 12 factors compared between the two stocks.

About Cardiovascular Systems

Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral, Predator 360, Stealth 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral, Diamondback 360 2.00 Peripheral, Diamondback 360 200cm Peripheral, and Diamondback 360 180cm Peripheral, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

About Amedica

Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers silicon nitride implants to surgeons and hospitals for use in cervical and thoracolumbar spine surgery under the Valeo brand. It also provides a line of non-silicon nitride spinal fixation products to address spinal deformity and degenerative conditions. The company markets and sells its products directly; and through a network of independent sales distributors, as well original equipment manufacturer and private label partnerships. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah.

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.